seed
Stage
1
Investors
About
iOrganBio is a Chapel Hill, North Carolina-based biotech company that develops an AI-powered cell manufacturing platform (CellForge) to automate and optimize production of human cells for therapeutic and research applications. The company launched from stealth in 2025 with $2M in funding and was founded in 2024.
Explore iOrganBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.